Onychomycosis
- PMID: 20347657
- DOI: 10.1016/j.clindermatol.2009.12.006
Onychomycosis
Abstract
Onychomycosis is a frequent nail disease caused by dermatophytes, yeasts, and nondermatophyte molds. Trichophyton rubrum, T mentagrophytes, and Epidermophyton floccosum are the most common etiologic agents worldwide. Candida spp are the most frequent among the yeasts. Diagnosis is corroborated by direct microscopic examination, culture, and histomycology with periodic acid-Schiff stain. Other new methods of diagnosis are discussed. Treatment is based on oral antifungals: terbinafine, itraconazole, and fluconazole, including other emerging triazole drugs. Therapeutic outcome with ciclopirox and amorolfine lacquers alone and combined with systemic therapy are also reviewed, as well as the new nail enhancers and physical and chemical removal of the diseased nails.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.Indian J Dermatol Venereol Leprol. 2007 Nov-Dec;73(6):393-6. doi: 10.4103/0378-6323.37056. Indian J Dermatol Venereol Leprol. 2007. PMID: 18032857 Clinical Trial.
-
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S81-95. doi: 10.1067/mjd.2000.109069. J Am Acad Dermatol. 2000. PMID: 11051137
-
Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.J Cutan Med Surg. 2001 May-Jun;5(3):206-10. doi: 10.1007/s102270000019. Epub 2001 May 2. J Cutan Med Surg. 2001. PMID: 11685666 Review.
-
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.Semin Cutan Med Surg. 2016 Mar;35(3 Suppl 3):S51-5. doi: 10.12788/j.sder.2016.009. Semin Cutan Med Surg. 2016. PMID: 27074700
-
Therapies for the treatment of onychomycosis.Clin Dermatol. 2013 Sep-Oct;31(5):544-54. doi: 10.1016/j.clindermatol.2013.06.011. Clin Dermatol. 2013. PMID: 24079583 Review.
Cited by
-
Growing Incidence of Non-Dermatophyte Onychomycosis in Tehran, Iran.Jundishapur J Microbiol. 2016 Jul 26;9(8):e40543. doi: 10.5812/jjm.40543. eCollection 2016 Aug. Jundishapur J Microbiol. 2016. PMID: 27800138 Free PMC article.
-
Virulence Factors and Antifungal Susceptibility in Candida Species Isolated from Dermatomycosis Patients.Mycopathologia. 2021 Mar;186(1):71-80. doi: 10.1007/s11046-020-00509-x. Epub 2020 Nov 20. Mycopathologia. 2021. PMID: 33216273
-
Onychomycosis in Two Populations with Different Socioeconomic Resources in an Urban Nucleus: A Cross-Sectional Study.J Fungi (Basel). 2022 Sep 24;8(10):1003. doi: 10.3390/jof8101003. J Fungi (Basel). 2022. PMID: 36294568 Free PMC article.
-
A case of onychomycosis caused by Aspergillus candidus.Med Mycol Case Rep. 2012 Jul 3;1(1):45-8. doi: 10.1016/j.mmcr.2012.06.003. eCollection 2012. Med Mycol Case Rep. 2012. PMID: 24371736 Free PMC article.
-
Different toenail onychomycosis due to Rhodotorula mucilaginosa and Candida parapsilosis in an immunocompetent young adult.Med Mycol Case Rep. 2019 Apr 28;24:69-71. doi: 10.1016/j.mmcr.2019.04.012. eCollection 2019 Jun. Med Mycol Case Rep. 2019. PMID: 31080710 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous